Compositions and methods relating to clostridium cochlearium and lactobacillus acidophilus

Abstract

Methods are provided according to aspects of the present disclosure which improve one or more of: impaired insulin sensitivity, overweight, obesity, glucose homeostasis dysregulation, and gut microbiota profile dysregulation. According to aspects of the present disclosure, methods of improving one or more of: impaired insulin sensitivity, overweight, obesity, glucose homeostasis dysregulation, and gut microbiota profile dysregulation include administering an effective amount of isolated C. cochlearium, isolated L. acidophilus or a combination of isolated C. cochlearium and isolated L. acidophilus, formulated together or separately, in a probiotic composition, to a subject in need thereof.

Dependencies are inferred from the claim text.